Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000899243-20-017715
Filing Date
2020-06-25
Accepted
2020-06-25 20:06:18
Documents
1
Period of Report
2020-06-25

Document Format Files

Seq Description Document Type Size
1 FORM 3 SUBMISSION doc3.html 3  
1 FORM 3 SUBMISSION doc3.xml 3 22657
  Complete submission text file 0000899243-20-017715.txt   24251
Mailing Address ONE NORTH WACKER DRIVE STE 2700 CHICAGO IL 60606-2807
Business Address ONE NORTH WACKER DRIVE STE 2700 CHICAGO IL 60606-2807 312-553-8486
ADAMS STREET PARTNERS LLC (Reporting) CIK: 0001193586 (see all company filings)

State of Incorp.: DE | Fiscal Year End: 1231
Type: 3 | Act: 34 | File No.: 001-39344 | Film No.: 20990655

Mailing Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6
Business Address 270 LONGWOOD ROAD SOUTH HAMILTON A6 L8P 0A6 289-799-0891
Fusion Pharmaceuticals Inc. (Issuer) CIK: 0001805890 (see all company filings)

EIN.: 000000000 | State of Incorp.: Z4 | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)